At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PEAnut Anaphylaxis Predictors
In Brief
A clinical study evaluating Questionnaire, Peanut Skin prick test, and 5 other interventions for Peanut Hypersensitivity and Anaphylaxis. Completed, enrolled 40 participants across 1 site.
Detailed Summary
Peanut allergy can be life-threatening. Current diagnostic techniques for peanut allergy have high sensitivity, but not high specificity. This clinical trial will test the validity of a novel blood biomarker (compared with current testing) as a diagnostic predictor of anaphylaxis to peanut.
Study Details
Timeline
Interventions
5 minute questionnaire focused on symptoms of allergic disease
Skin prick testing with peanut antigen, according to ASCIA Skin Prick testing manual
Measurement of exhaled nitric oxide, according to American Thoracic Society/ European Thoracic Society (ATS/ERS) standardised procedures (Not required for those age less than 6 years).
Measurement of lung flows/volumes, according to ATS/ERS standardised procedures (Not required for those age less than 6 years).
Peanut and Ara h2 specific IgE antibodies
Correlation of blood biomarker levels in patients with successful or unsuccessful peanut food challenge
Open label peanut challenge conducted according to ASCIA's peanut challenge protocol and PRACTALL consensus report